Bio-Rad Laboratories, Inc.
BIO · NYSE
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $398 | $369 | $521 | $488 |
| Short-Term Investments | $1,023 | $1,005 | $1,139 | $1,176 |
| Receivables | $474 | $470 | $425 | $453 |
| Inventory | $783 | $799 | $790 | $760 |
| Other Curr. Assets | $12 | $19 | $36 | $31 |
| Total Curr. Assets | $2,842 | $2,811 | $3,037 | $3,030 |
| Property Plant & Equip (Net) | $0 | $740 | $682 | $689 |
| Goodwill | $579 | $582 | $415 | $411 |
| Intangibles | $388 | $397 | $296 | $294 |
| Long-Term Investments | $5,058 | $5,577 | $4,994 | $4,839 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $829 | $108 | $104 | $102 |
| Total NC Assets | $6,854 | $7,403 | $6,490 | $6,334 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $9,696 | $10,214 | $9,527 | $9,364 |
| Liabilities | – | – | – | – |
| Payables | $129 | $139 | $138 | $122 |
| Short-Term Debt | $38 | $1 | $1 | $1 |
| Tax Payable | $45 | $36 | $37 | $31 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $311 | $175 | $132 | $147 |
| Total Curr. Liab. | $522 | $549 | $507 | $468 |
| LT Debt | $1,193 | $1,201 | $1,201 | $1,200 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $873 | $961 | $841 | $818 |
| Other NC Liab. | $208 | $210 | $173 | $177 |
| Total NC Liab. | $2,437 | $2,537 | $2,341 | $2,327 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $193 | $204 | $0 | $173 |
| Total Liabilities | $2,960 | $3,085 | $2,848 | $2,795 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | $7,456 | $7,798 | $7,480 | $7,416 |
| AOCI | -$167 | -$154 | -$410 | -$538 |
| Other Equity | $0 | $0 | $0 | $0 |
| Total Equity | $6,737 | $7,129 | $6,679 | $6,569 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $9,696 | $10,214 | $9,527 | $9,364 |
| Net Debt | $833 | $833 | $681 | $714 |